BioWorld MedTech

Jan. 27, 2012

Patients have better quality of life when treated with IMRT

A new study shows that patients treated with intensity modulated radiation therapy (IMRT), have an increasingly better quality of life post treatment when compared to patients receiving other forms of radiation therapy. Read More

Report from Europe: Boston Scientific welcomes new NICE guidance on BT for asthma

'Quest' for companion diagnostics: Personalized approach renews Tysabri's potential in MS space

Washington roundup: CDRH will commence with triage of applications in April

Financings roundup: Sequenom raises about $62M in gross proceeds from stock sale

Deals roundup: Bruker acquires assets of Hecus's MicrocaliX line

Patent roundup: EF Precision Group receives patent for new orthopedic mallet

Agreements/contracts: M*Modal in partnership with Merge for speech technology

Court report: Court denies motion to stop NuVasive sales

HIT roundup: Integware reports teaming up with Siemens PLM Software

Med-Tech Notes: Catholic Healthcare West now Dignity Health

People in the News

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

SERCA inhibitor from Sumitomo shows promise for MSA-C treatment

BioWorld Science

At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....